Zenas BioPharma CEO Leon O. Molder Jr. Purchases 60,000 Shares

Leon O. Molder Jr., CEO of Zenas BioPharma (NASDAQ:ZBIO), purchased 60,000 shares at a weighted average price of $16.88 per share in an open-market transaction reported via SEC Form 4. This purchase aligns with his historical accumulation pattern and increases his direct ownership to approximately 0.95% of the company's outstanding shares.

By Robert Izquierdo, The Motley Fool Sun, June 21, 2026 at 2:31 PM GMT+3 4 min read · Yahoo Finance · June 21, 2026, 11:31 UTC

Tickers: $ZBIO

Topics: CEO purchase SEC Form 4 filing Zenas BioPharma shares

Read the full article at Yahoo Finance

More World news

California Supreme Court to Rule on Insurance Overcharge Liability Under Proposition 103 PR Newswire · November 12, 2026, 18:44 UTC
Federal Court Orders Veterans Guardian to Pay Treble Damages to Disabled Veteran Class PR Newswire · November 12, 2026, 18:41 UTC
AIRO Group Holdings Reaffirms 2026 Revenue Growth Guidance Amid $200 Million Drone Backlog Seeking Alpha · November 12, 2026, 18:40 UTC
Nvidia CEO Jensen Huang Resigns Amid Personal Scandal, Raising Uncertainty for Open Source AI Strategy TechCrunch · November 12, 2026, 18:39 UTC
Vor Bio and RemeGen Expand Collaboration for Autoimmune Disease Therapy Seeking Alpha · November 12, 2026, 18:35 UTC
EnterpriseDB Hires CMRD Engineering Team to Strengthen Sovereign AI Governance PR Newswire · November 12, 2026, 18:36 UTC
Alliant Credit Union Executive Meredith Ritchie Named 2027 Chicago Titan 100 Honoree PR Newswire · November 12, 2026, 18:36 UTC
Fed's Schmid Argues Construction Productivity is Key to Housing Affordability Over Interest Rate Cuts Seeking Alpha · November 12, 2026, 18:33 UTC
PROG Holdings Reports 59% GMV Growth and Announces $100 Million Share Repurchase Program Motley Fool · November 12, 2026, 18:30 UTC
Corteva Shares Plunge Over Q3 Earnings Miss and Pricing Pressures Motley Fool · November 12, 2026, 18:31 UTC